Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1983 Sep;41(3):965–970. doi: 10.1128/iai.41.3.965-970.1983

Natural killer cell activity in renal transplant recipients receiving cyclosporine.

X E Gui, C R Rinaldo Jr, M Ho
PMCID: PMC264595  PMID: 6309674

Abstract

Normal subjects (n = 11) had a mean circulating natural killer (NK) cell activity of 188 lytic units per 10(7) peripheral mononuclear blood leukocytes. This activity was significantly enhanced by in vitro incubation with 500 U of alpha-interferon (+207 lytic units). The mean NK activity of renal transplant recipients on azathioprine (n = 17) or on cyclosporine (n = 17) studied at various times after transplantation was significantly decreased, as was the ability of interferon to enhance NK activity. In the cyclosporine group, interferon could not enhance NK titers 1 to 6 weeks after transplantation when the patients were on the highest doses of cyclosporine (mean, 1,002 mg/day) or when they were viremic for cytomegalovirus. After 18 weeks, when the patients received 546 mg/day or when viremia was no longer detected, the ability of interferon to enhance NK activity was more normal. Cyclosporine and cytomegalovirus infection may have a greater effect on the action of interferon on NK activity than on the NK titer per se. This defect may diminish the reserve of NK cells and contribute to post-transplant immunosuppression.

Full text

PDF
965

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson L. C., Nilsson K., Gahmberg C. G. K562--a human erythroleukemic cell line. Int J Cancer. 1979 Feb;23(2):143–147. doi: 10.1002/ijc.2910230202. [DOI] [PubMed] [Google Scholar]
  2. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  3. Breinig M. C., Ho M., White L., Armstrong J. A., Pazin G. J., Haverkos H. W., Cantell K. Effect of prolonged administration of interferon-alpha on pharmacokinetics, fever, lymphocyte proliferative response, and NK cell activity. J Interferon Res. 1982;2(2):195–207. doi: 10.1089/jir.1982.2.195. [DOI] [PubMed] [Google Scholar]
  4. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  5. Cerottini J. C., Engers H. D., Macdonald H. R., Brunner T. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. J Exp Med. 1974 Sep 1;140(3):703–717. doi: 10.1084/jem.140.3.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gui X., Ho M., Camp P. E. Effect of cyclosporin A on murine natural killer cells. Infect Immun. 1982 Jun;36(3):1123–1127. doi: 10.1128/iai.36.3.1123-1127.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guillou P. J., Hegarty J., Ramsden C., Davison A. M., Will E. J., Giles G. R. Changes in human natural killer activity early and late ater renal transplantation using conventional immunosuppression. Transplantation. 1982 Apr;33(4):414–421. doi: 10.1097/00007890-198204000-00015. [DOI] [PubMed] [Google Scholar]
  8. Ho M. Virus infections after transplantation in man. Brief review. Arch Virol. 1977;55(1-2):1–24. doi: 10.1007/BF01314475. [DOI] [PubMed] [Google Scholar]
  9. Ho M., White L. T., Haverkos H. W., Breinig M. C., Pazin G. J., Armstrong J. A. Depression of natural killer cell activity by interferon. J Infect Dis. 1981 Dec;144(6):605–605. doi: 10.1093/infdis/144.6.605. [DOI] [PubMed] [Google Scholar]
  10. Lipinski M., Tursz T., Kreis H., Finale Y., Amiel J. L. Dissociation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients receiving high-dose immunosuppressive therapy. Transplantation. 1980 Mar;29(3):214–218. doi: 10.1097/00007890-198003000-00010. [DOI] [PubMed] [Google Scholar]
  11. Lozzio C. B., Lozzio B. B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 1975 Mar;45(3):321–334. [PubMed] [Google Scholar]
  12. Melder R. J., Ho M. Modulation of natural killer cell activity in mice after interferon induction: depression of activity and depression of in vitro enhancement by interferon. Infect Immun. 1982 Jun;36(3):990–995. doi: 10.1128/iai.36.3.990-995.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Moreau J. F., Ythier A., Soulillou J. P. Natural killer activity in kidney allograft recipients. Transplant Proc. 1981 Sep;13(3):1610–1613. [PubMed] [Google Scholar]
  14. Ortaldo J. R., Bonnard G. D., Herberman R. B. Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol. 1977 Oct;119(4):1351–1357. [PubMed] [Google Scholar]
  15. Oshimi K., Gonda N., Sumiya M., Kano S. Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. Clin Exp Immunol. 1980 Apr;40(1):83–88. [PMC free article] [PubMed] [Google Scholar]
  16. Quinnan G. V., Manischewitz J. E., Ennis F. A. Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature. 1978 Jun 15;273(5663):541–543. doi: 10.1038/273541a0. [DOI] [PubMed] [Google Scholar]
  17. Rinaldo C. R., Jr, Carney W. P., Richter B. S., Black P. H., Hirsch M. S. Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis. 1980 Apr;141(4):488–495. doi: 10.1093/infdis/141.4.488. [DOI] [PubMed] [Google Scholar]
  18. Rinaldo C. R., Jr, Ho M., Hamoudi W. H., Gui X. E., DeBiasio R. L. Lymphocyte subsets and natural killer cell responses during cytomegalovirus mononucleosis. Infect Immun. 1983 May;40(2):472–477. doi: 10.1128/iai.40.2.472-477.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thiru S., Calne R. Y., Nagington J. Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents. Transplant Proc. 1981 Mar;13(1 Pt 1):359–364. [PubMed] [Google Scholar]
  20. Welsh R. M. Natural cell-mediated immunity during viral infections. Curr Top Microbiol Immunol. 1981;92:83–106. doi: 10.1007/978-3-642-68069-4_6. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES